Objective: In patients with symptomatic aortic valve stenosis and a high estimated operative risk due to previous coronary artery bypass grafting (CABG) procedures, interventional aortic valve implantation techniques may ultimately prove superior. However, recent studies have revealed increased mortality and impaired survival in patients with concomitant coronary artery disease (CAD). Methods: Between January 1996 and May 2010, 60 patients (73 AE 6 years, 15 female (25%)) underwent conventional operation 9 AE 6 years after CABG for symptomatic aortic valve stenosis (European System for Cardiac Operative Risk Evaluation, EuroSCORE) standard 11 AE 3%, logistic 27 AE 17%, Society of Thoracic Surgeons (STS) Score 19 AE 8%). Coronary angiography revealed open grafts and no need for further revascularization in all patients. High-risk patients were identified (log. EuroSCORE ! 20%, n = 34) and divided by age (<75 years, n = 15; !75 years, n = 19) for sub-group analysis. Follow-up for all 60 patients was performed according to the current guidelines: quality of life was assessed using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). Results: Thirty-day-mortality was 5% (n = 3). During follow-up (100% complete), 18 patients died. Thus, 1-, 3-and 5-year survival was 91%, 77%, and 69%, respectively. No differences in survival could be detected between the two high-risk groups. Quality of life revealed excellent results for the entire cohort, as well as both high-risk groups. Conclusions: Conventional surgery in patients with symptomatic aortic valve stenosis after previous CABG can be performed with excellent results despite a high calculated risk, independent of age. Although conventional surgery is technically more demanding and associated with substantial surgical trauma, it is justified by the excellent survival and high quality of life in this high-risk patient cohort. #
Introduction
Over the past several years, life expectancy has increased in industrial nations, but has been accompanied by a rising rate of elderly patients with multiple illnesses [1] . Moderate or severe aortic valve disease has a prevalence of approximately 4-5% in people !75 years [2] . The best option for patients with severe aortic valve stenosis (AVS) who suffer from dyspnea, angina and/or syncope is conventional valve replacement (AVR) [3] , as conservative therapy in symptomatic patients has been reported to have a mortality rate as high as 34%. Interestingly, only 30% of these patients were evaluated by a cardiac surgeon, presumably due to a high operative risk assumed by the cardiologists [2] .
In 2002, Cribier and co-workers introduced a new technique of percutaneous implantation of an aortic valve (AVI) via a trans-femoral approach (TF-AVI), originally designed for end-stage inoperable patients [4] . An alternative approach is the technique of transapical aortic valve implantation (TA-AVI) [5] . In the early days of AVI, only highrisk patients were selected (e.g., logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE) > 20%, age !75 years) or contraindications for surgery [6] . More recently, the recommendations have been liberalized in some high volume centers, especially if previous cardiac surgery has been done [7, 8] . Patients who have had previous coronary artery bypass grafting (CABG) with patent grafts and severe AVS are considered high risk, but our group has shown recently that the calculated risk for conventional surgery is significantly overestimated [9] .
Recent studies have shown that coronary artery disease (CAD), indicated by previous percutaneous coronary intervention (PCI) or CABG, negatively affects outcome and longterm-survival in patients subjected to AVI techniques [10] . Survival of patients with CAD and AVI is comparable to patients treated conservatively [2] . The quality of life of the patients following conventional AVR, minimally invasive interventions, or treated conservatively has not been systematically considered. The objective of the current study was to evaluate patients undergoing AVR as a redo procedure after CABG, with the focus on outcome, complications and quality of life [11] .
Patients and methods
This study was approved by the institutional review board, and all patients gave informed consent. From January 1996 to May 2010, 4808 patients underwent inter alia an operation on the aortic valve at our institution. Of these, 161 patients had a history of previous CABG. Sixty patients with patent grafts underwent only isolated AVR. Patients with previous valve replacements, endocarditis or concomitant diseases (e.g., ascending aortic aneurysms) -all not suitable for interventional approaches -were excluded from analysis.
The pre-, intra-and postoperative data of these patients were analyzed retrospectively. The patient cohort was divided into different groups: all patients (n = 60); patients with a logistic EuroSCORE !20% (n = 34), and these high-risk patients redivided into age groups: 15 less than age 75 years, and 19 patients 75 years of age or older (Table 1 ). In addition to the standard and logistic EuroSCORE, the Society of Thoracic Surgeons (STS) Risk Score for mortality and morbidity were also calculated ( Table 2) .
Preoperative
Our institutional policy involves discussion by an interdisciplinary team of surgeons and cardiologists concerning the assets and drawbacks of a conventional intervention versus percutaneous AVI according to current guidelines [6] . TA-AVI and TF-AVI are performed in special high-risk cases, but due to the excellent results achieved with conventional AVR, this technique is considered the method of choice whenever possible.
All patients underwent preoperative standard examinations as described previously [9] . In addition to the routinely performed diagnostic tests, a high-resolution computed tomography scan to visualize bypass grafts and distances to the sternum is essential for proper preoperative planning [12] .
Intra-operative
The operative technique includes a careful median resternotomy, cannulation of the ascending aorta and mild hypothermia. To protect the myocardium, cold-blood cardioplegia was given in antegrade fashion in the majority of cases, otherwise, crystalloid cardioplegia was used. In selected cases, retrograde cardioplegia was given, and in three cases the operation was performed without any cardioplegia under moderate hypothermia without aortic cross-clamping. According to the patient's preference, age and life expectancy, either a mechanical or biological prosthesis was implanted.
Postoperative
Myocardial infarction was defined as a significant increase in postoperative creatine kinase levels, as well as specific electrocardiogram (ECG) changes and hemodynamic instability. In patients with persistent postoperative atrioventricular block, permanent pacemaker implantation was performed during a second operation. Dialysis was counted if new renal insufficiency occurred. A patient was considered to have a perioperative stroke if, after onset of neurological symptoms, a computed tomography scan of the brain revealed signs of embolization or bleeding. All other cases were documented as temporary neurological dysfunction (TND).
Follow-up
All follow-up patients were surveyed at least 3 months after the operation, following rehabilitation and return to familiar surroundings. For the latest detailed medical information, current diagnostic tests from general practitioners and referring cardiologists were requested. Furthermore, all patients were personally interviewed by phone. In addition, the Minnesota Living with Heart Failure Questionnaire (MLHFQ) was completed by the patient. Follow-up data were assessed according to the guidelines for reporting mortality and morbidity after cardiac valve interventions [11] .
Quality of life
For this purpose, we used the MLHF Questionnaire, which measures the effect of heart failure and its treatments on an individual's quality of life in physical (functional limitations), emotional (psychological distress), social and mental dimensions. The MLHFQ is a 21-item structured questionnaire that can be self-administered within 5 min. A patient with zero points is evaluated as asymptomatic; 21 points are counted as minor restrictions, and 105 points mean heavy limitations due to heart failure. Standardized scores are not available; an average score between 28 and 43 corresponds to New York Heart Association (NYHA)-Class II and III [13] . The returned MLHF Questionnaires were analyzed under the terms of its official instructions for data collecting and scoring.
Statistical analysis
Results are expressed as mean AE standard deviation, or percentage. Statistical analysis for group comparison was performed using the unpaired t-test, chi-square test or Fisher's exact test, as appropriate. Forward stepwise logistic regression analysis (likelihood ratio) was used to discriminate risk factors for 30-, 60-and 90-day mortality. The predicted probability of the event as well as the predicted group membership for mortality was calculated for each case. The Kaplan-Meier survival estimate was used to analyze survival. Statistical differences in Kaplan-Meier survival were determined with the log-rank test. A p-value of less than 0.05 was deemed to be significant. Statistical Package for Social Sciences (SPSS) 17.0 software was used for statistical analysis in co-operation with the Department of Biometrics of Hannover Medical School. 
Results

Risk scores
The mean logistic EuroSCORE of the whole study population was 27% AE 17%, and the mean STS Risk Score for mortality was 19% AE 8%, in 95% > 10%. To evaluate a possible impact of age and risk score, a sub-group analysis for high-risk patients (log. EuroSCORE ! 20%) was performed. In contrast to the logistic EuroSCORE, the STS risk score revealed statistically significant differences between the two high-risk groups for the STS risk of mortality (25% vs 18%, p = 0.01) and risk of re-operation (22% vs 20%, p = 0.03), with a higher risk in the patients !75 years. There was also a trend toward a higher risk for morbidity or mortality ( p = 0.06), long length of stay ( p = 0.08), and permanent stroke ( p = 0.07) in the elderly patients, as shown in Table 2 .
Intra-operative data
Operative times were comparable between groups. A total of 18 (30%) mechanical and 42 (70%) biological valves were implanted, ranging from 19 to 27 mm in size. Valves were provided by the following companies (alphabetical order): Baxter, Edwards Lifesciences, Medtronic, Sorin, and St. Jude Medical. Detailed operative data are shown in Table 3 . Two intra-aortic balloon pumps were implanted during reperfusion: one in a patient with intra-operative right heart failure, and another due to preoperative cardiac decompensation.
During the first 90 days, four patients died: three during the first 30 days (multi-organ failure, stroke, and pulmonary edema); one within 90 days due to therapy of refractory ventricular fibrillation. Two of them received a tracheotomy; one required dialysis (new).
Six patients suffered from postoperative neurological symptoms; four (67%) with a previous history of neurological events. In three patients, computed tomography scans of the brain were positive for cerebral infarction. Of these patients, one died (see above), and two were discharged home without residua. Three patients suffered from TND.
No myocardial infarction was detected postoperatively by means of repeated ECG analysis and creatine kinase values.
After a mean hospital stay of 14 AE 15 days, patients were discharged home or referred to a regular rehabilitation facility. No significant differences could be evaluated in the length of the hospital stay between the older and the younger group.
Logistic regression analysis
None of the preoperative risk factors (Table 1 * ) entered in the model achieved significant results for the 30-, 60-, or 90-day mortality. The predicted probability for the 30-daymortality ranged between 3.5 and 6.5% (95% confidence interval (CI). Age ( p = 0.3, 95% CI for EXP(B) 0.9-1.5) as well as the log. EuroSCORE ( p = 0.3, 95% CI-interval for EXP(B) 1-1.1) had no impact on the 30-day-mortality.
Follow-up
Mean follow-up was 38 months; the minimum was 3 months after the AVR and was completed in 100%. In Fig. 1 , the mortality of the patients during the first 3 months is plotted. The highest risk patients (log. EuroSCORE > 20, !75 years of age) seemed to have a higher mortality during this period, but this did not reach statistical significance. Kaplan-Meier survival estimates for the entire group revealed a 1-, 2-, 3-, and 5-year survival of 91%, 87%, 77%, and 69% respectively. In the high-risk groups, no differences in survival could be detected (log rank test, p = 0.19) (Fig. 2) .
The follow up conforming to guidelines is shown in Table 4 . One asymptomatic patient had non-structural valve dysfunction (paravalvular leakage) and refused re-AVR. No structural Table 3 . Intra-operative data.
Items
All patients (n = 60) valve deterioration could be detected. The implanted valves had good hemodynamic function with low aortic gradients and an ejection fraction ! 30% in all but two patients. The majority of patients had optimal postoperative medical therapy for heart failure and anticoagulation (data not shown).
Quality of life
The analysis of the MLHFQ was completed in 95% (40 of 42 patients): one patient was not able to answer due to dementia unrelated to AVR (Table 5) . The values of the entire group as well for the high-risk patients are plotted in Fig. 3 . In this questionnaire, a patient with only minor restrictions has a calculated total score of 21. No significant differences between groups were found.
Discussion
In a recent publication, Bach and co-workers presented the results of a multicenter study of patients with severe symptomatic AVS, who did not undergo aortic valve replacement [2] . They investigated the potential role of subjectively overestimated operative risk. Half of the investigated symptomatic patients were not referred for surgery because of co-morbidities, which were presumed to present a high operative risk. Interestingly, the calculated risk for this cohort using the STS Risk Calculator was only 3.8%. Of all unoperated patients, only 30% were evaluated by a cardiac surgeon. One-year mortality was 33% for symptomatic and 7% for asymptomatic patients.
For end-stage inoperable patients, the technique of TF-AVI or TA-AVI techniques may be an alternative to conservative treatment [4, 5] . Currently, patient inclusion for these techniques is based on guidelines published by the different societies [6] . So-called high-risk patients were selected by a combination of different established scores (e.g., EuroSCORE and STS Risk Calculator), age and other risk factors not covered by the scores (e.g., previous aortocoronary bypass with patent grafts). The latest study results from the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry reveal that patients with very high logistic EuroSCORES may not benefit in the midterm [14] . In view of this finding, it seems appropriate to question whether patients included in the TA-AVI group were really inoperable, as suggested by a recent propensity score analysis [15] . It has been shown by several investigators that, especially, the logistic EuroSCORE overestimates operative risk for AVR [16, 17] . This is especially true in patients after previous CABG with patent grafts with high calculated risk scores [9] . At the present time, therefore, one must question whether the EuroSCORE should be recommended for prediction of outcome after AVR [18] .
The promising results from the Leipzig group led them to conclude that particularly elderly patients with aortic stenosis after CABG represent a good target population for TA-AVI [8] . In their opinion, the open grafts may protect the native coronary arteries during the procedure. They conclude that preservation of (even stenosed) native coronary arteries should be the goal in all implantations. Follow-up was limited due to the low number of patients, with a 72% survival after 1 year.
In a recent study, the Berlin group reported a 30-day mortality of only 5% in patients receiving TA-AVI after previous heart surgery, but 1.5-year survival was only 52% despite a mean age of 75 years. Furthermore, 40% of the patients had paravalvular leakage. In addition, as the group [ ( ) T D $ F I G ] pointed out, there is a noteworthy danger of damaging grafts during manipulation with guide wires or valve positioning [7] . Dewey and co-workers estimated that patients with CAD were 10.1 times more likely to die within 30 days after AVI compared with patients without CAD. One-year survival in patients with CAD was significantly different from those without CAD (58% vs 65%) in the pooled TA/TF-AVI group. In the TA-AVI group, mortality was 45% in the first year, compared with 30% in the TF-AVI group. Furthermore, patients with CAD had a peri-interventional stroke rate of 13.1%; 64% of these patients died [10] .
In 2008, the American Association for Thoracic Surgery (AATS), STS, and European Association of Cardio-Thoracic Surgery (EACTS) published guidelines to report mortality and morbidity after cardiac valve interventions [11] . Unfortunately, only the minority of articles dealing with these issues conforms to the recommendations, making a comparison between results of the different studies complicated.
In Germany, conventional AVR is performed with an operative mortality of 3.4%; in combination with CABG, mortality following AVR increases to 5.4% [19] . With advanced age, however, mortality increases, especially in octogenarians [20] . The German Society of Cardiothoracic Surgery has shown that the EuroSCORE significantly overestimates the mortality for different types of heart surgery in Germany [17] . Based on these results, the 5% 30-day mortality (n = 3) in our special patient cohort is remarkable. During the first year, only two further patients died.
Antunes and co-workers have shown that conventional AVR is associated with excellent in-hospital mortality rates. Furthermore, long-term survival, independent of patient age, is also remarkable [21] .
Mid-term (5-year) survival in the cohort presented here was 69%, and not adversely affected by age. The stroke rate was low, causing death in only one patient; two others recovered without any neurological deficits. In contrast to these findings, the incidence of stroke in the AVI cohorts is much higher, with a significant proportion of fatal outcomes (as mentioned previously) [10] . Assessment of quality of life is paramount in these patients [6] . Operative success should not be the only criterion for choosing a procedure for the individual patient. In addition to a guideline-conforming account of follow-up, a measurement tool for quality of life metrics should be included in surgical studies. We were able to achieve excellent results in our special subset of patients, independent of patient age and EuroSCORE. Quality-of-life scores (MLHFQ) were equivalent to NYHA Class II functional status [13] . Together with the excellent performance of the implanted valves (only one instance of structural valve deterioration), postoperative quality of life should also be considered before allocating a patient to an AVI technique or conservative therapy instead of scheduling them for conventional surgery [22] . The referring cardiologists as well as general practitioners are important partners in this context. The good results achieved in this study are likely to have been enhanced by optimal heart failure medication postoperatively, and by close follow-up.
To avoid AVR after CABG, the replacement of the aortic valve during initial CABG surgery in cases of mild stenosis or calcification of the valve should be discussed, especially in younger patients with a high burden of co-morbidities. There was a trend toward earlier re-operation in the younger subcohort (6 years for patients < 75 years vs 10 years in those !75 years, p = 0.09) in the current study. Unfortunately, the majority of the patients were operated on elsewhere initially, leaving us with incomplete data about the status of the aortic valve at the time of initial CABG surgery. Various authors recommend replacement of the aortic valve during CABG surgery, if certain criteria are present (e.g., if the peak gradient is greater than 30 mmHg and the patient's age is 75 years) [23, 24] . Thus far, operative mortality for combined CABG/AVR procedures is higher than for isolated CABG (5.4% vs 2.8%) [19] . In the future, the risk may be reduced by newer sutureless AVR techniques with shorter aortic cross-clamp times [25] .
Limitations
The number of patients presented in this study is too low to establish an accurate estimate of operative risk for this patient cohort. We do not know the number of patients, who were not referred to our institution for AVR after CABG because of a potentially high operative risk. Because of the retrospective design, no preoperative quality-of-life data were available. Nevertheless, to the best of our knowledge, this is the largest single-center experience in this special high-risk patient cohort.
Conclusion
From the studies published thus far, the idea of reducing mortality and morbidity with TA-AVI or TF-AVI in patients requiring AVR after previous CAGB by avoiding re-sternotomy seems to have failed. Despite initial successful implantation, mortality rates increase dramatically during follow-up.
With optimal pre-and intra-operative management, conventional surgery is feasible in many of these patients, with a low perioperative morbidity and mortality. Excellent follow-up results, including quality-of-life data, have made conventional AVR the method of choice in our institution whenever possible. This is not to deny that other subsets of patients may benefit from AVI techniques. Our experience suggests that recommendations for AVI should be made after interdisciplinary consideration of each patient, and should not depend solely on standardized risk score calculations.
